Evaluating Serum Sestrin in Leiomyoma Patients
Study Details
Study Description
Brief Summary
Leiomyomas are the most common benign neoplasms of women's reproductive system affecting 20-30% of women within the reproductive ages. Sestrins are serum proteins which are highly expressed under circumstances of DNA damage, hypoxia and oxditive stress and play an important role in autophagia. The aim of this study is to evaluate the relationship of serum sestrin proteins with development of leiomyomas.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Leiomyomas are the benign neoplasms of uterus and the role of genetics, estrogen levels and obesity has already been shown in their development. Higher levels of serum sestrin proteins have already been associated with DNA damage, hypoxia and oxidative stress and sestrin plays an important role in autophagia. In order to evaluate the role of serum sestrin in the development of leiomyomas 30 patients between 18-45 years of age who were diagnosed with uterine leiomyomas with transvaginal ultrasonography will be included in the study group. Their serum sestrin levels will be determined and compared with that of 30 healthy subjects recruited during the same study period at the same clinic.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Study Group 30 patients within the reproductive ages (18-45 years) who were diagnosed with leiomyomas using transvaginal ultrasonography without any additional chronic, systemic or autoimmune disease, are not currently using any medical, hormonal, antiinflammatory treatments are included in this group. |
Other: Determination of serum sestrin levels
Serum sestrin levels will be determined using venous blood samples obtained from the subjects.
|
| Control Group 30 healthy subjects within the reproductive ages (18-45 years) who visited the outpatient gynecological clinic for routine examination who do not have any additional chronic, systemic or autoimmune disease, who are not currently using any medical, hormonal, antiinflammatory treatments are included in this group. |
Other: Determination of serum sestrin levels
Serum sestrin levels will be determined using venous blood samples obtained from the subjects.
|
Outcome Measures
Primary Outcome Measures
- Evaluating the role of autophagia in the development of leiomyomas by evaluating the serum sestrin levels. [2 months]
Increased levels of serum sestrin proteins are associated with impaired autophagia. This association will be evaluated in the context of leiomyoma patients by measuring serum sestrin levels in blood samples obtained from these patients and comparing them with the sestrin levels measured in healthy subjects.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18-45 years of age
-
patients diagnosed with uterine leiomyomas will be included in the study group
-
patients without any additional comorbidities
-
patients without any autoimmune diseases
Exclusion Criteria:
-
patients with systemic diseases
-
patients with known chronic inflammatory diseases
-
patients using hormonal and/or medical therapy
-
pregnant women
-
lactating women
-
patients with malignant diseases
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Sisli Hamidiye Etfal Training and Research Hospital | Istanbul | Turkey | 34371 |
Sponsors and Collaborators
- Sisli Hamidiye Etfal Training and Research Hospital
Investigators
- Study Director: Pinar Yalcin Bahat, MD, University of Health Sciences Turkey, Istanbul Kanuni Sultan Suleyman Training and Research Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Myomsestrin